Hematopoietic Stem Cells Can Be CD34+ or CD34-

References

• Civin C. I., Strauss L. C., Brovall C., Fackler M. J., Schwartz J. F., Shaper J. H. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-la cells. J. Immunol 1984; 133: 157–165
   PubMed Web of Science ®Google Scholar
• Katz F. E., Tindle R., Sutherland D. R., Greaves M. F. Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. Leuk. Res 1985; 9: 191–198
   PubMed Web of Science ®Google Scholar
• Andrews R. G., Singer J. W., Bernstein I. D. Monoclonal antibody 12–8 recognizes a 115-kd molecular present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986; 67: 842–845
   PubMed Web of Science ®Google Scholar
• Andrews R. G., Singer J. W., Bernstein I. D. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 1989; 169: 1721–31
   PubMed Web of Science ®Google Scholar
• Sutherland D., Eaves C., Eaves A., Dragowska W., Lansdorp P. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74: 1563–68
   PubMed Web of Science ®Google Scholar
• Sutherland H. J., Lansdorp P. M., Henkelman D. H., Eaves A. C., Eaves C. J. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci U S A 1990; 87: 3584–8
   PubMed Web of Science ®Google Scholar
• Andrews R. G., Singer J. W., Bernstein I. D. Human hematopoietic precursors in long-term culture: single CD34+ cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colony-forming cells when cultured with marrow stromal cells. J Exp Med 1990; 172: 355–358
   PubMed Web of Science ®Google Scholar
• Terstappen L. W.M. M., Huang S., Safford M., Lansdorp P. M., Loken M. R. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+ CD38− progenitor cells. Blood 1991; 77: 1218–1227
   PubMed Web of Science ®Google Scholar
• Civin C. I., Trischmann T. M., Fakcler M. J., Bernstein I. D., Buehring H. J., Campos L., Greaves M. F., Kamoun M., Katz D. R., Lansdorp P. M., Look A. T., Seed B., Sutherland D. R., Tindle R. W., Uchanska-Ziegler B. Summary of CD34 Cluster Workshop Section. Leukocyte Typing IV, W. Knapp, B. Dorken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, A. E.G. von dem Borne. Oxford University Press, Oxford 1990; 818–825
   Google Scholar
• Debili N., Coulombel L., Croisille L., Katz A., Guichard J., Breton-Gorius J., Vainchenker W. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 1996; 88: 1284–96
   PubMed Web of Science ®Google Scholar
• Loken M. R., Shah V. O., Dattilio K. L., Civin C. I. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987; 70: 1316–24
   PubMed Web of Science ®Google Scholar
• Loken M. R., Shah V. O., Dattilio K. L., Civin C. I. Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 1987; 69: 255–63
   PubMed Web of Science ®Google Scholar
• Spits H., Lanier L. L., Phillips J. H. Development of human T and natural killer cells. Blood 1995; 85: 2654–70
   PubMed Web of Science ®Google Scholar
• Berenson R. J., Andrews R. G., Bensinger W. I., Kalamasz D., Knitter G., Buchner C. D., Bernstein D. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J. Clin. Invest 1988; 81: 951–955
   PubMed Web of Science ®Google Scholar
• Andrews R., Bryant E., Bartelmez S., Muirhead D., Knitter G., Bensinger W., Strong D., Bernstein I. CD34+ marrow cells devoid of T and B lymphocytes, reconstitute stable lymphopoeisis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 1992; 80: 1693–701
   PubMed Web of Science ®Google Scholar
• Wagermaker G., van Gils F., Bart-Baumeister J., Weilenger J., Levinsky R. Sustained engraftment of allogenic CD34 positive hematopoietic stem cells in rhesus monkeys. Exp Hematol 1990; 18: 708
   Google Scholar
• Berenson R. J., Bensinger W. I., Hill R. S., Andrews R. G., Garcia-Lopez J., Kalamasz D. F., Still B. J., Spitzer G., Buckner C. D., Bernstein I. D., Thomas E. D. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer neuroblastoma. Blood 1991; 77: 1717–1722
   PubMed Web of Science ®Google Scholar
• Civin C. I., Trischmann T., Davis J., Noga S., Cohen K., Duffy B., Wiley J., Law P., Hardwick A., Oldham F., Gee A. Highly Purified CD34+ Cells Reconstitute Hematopoiesis. Proc. Am. Soc. Clin. Oncol 1995; 14: 437
   Web of Science ®Google Scholar
• Shpall E. J., Jones R. B., Purdy M. H., Franklin W. A., Heimfeld S., Berenson R. J. Transplantation of CD34+ marrow and/or peripheral blood progenitor cells (PBPCs) into patients with breast cancer or non-hodgkin's lymphoma following high dose chemotherapy. Exp. Hematol 1994; 22: 774
   Web of Science ®Google Scholar
• Shpall E., Jones R., Bearman S., Franklin W., Archer P., Curiel T., Bitter M., Claman H., Sterner S., Purdy M., Myers S., Hami L., Taffs S., Heimfeld S., Hallogan J., Berenson R. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol 1994; 12: 28–36
   PubMed Web of Science ®Google Scholar
• Bensinger W. I., Clift R., Martin P., Appelbaum F. R., Demirer T., Gooley T., Lilleby K., Rowley S., Sanders J., Storb R., Buckner C. D. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794–800
   PubMed Web of Science ®Google Scholar
• Cometta K., Gharpure V., Mills B., Hromas R., Abonour R., Broun E. R., Traycoff C. M., Hanna M., Wyman N., Danielson C., Gonin R. K.K. L., Oldham E., Srour E. F. Rapid engraftment after allogeneic transplantation using CD34-enriched marrow cells. Bone Marrow Transplant 1998; 21: 65–71
   PubMed Web of Science ®Google Scholar
• Colter M., Jones M., Heimfeld S. CD34+ progenitor cell selection: clinical transplantation, tumor cell purging, gene therapy, ex vivo expansion, and cord blood processing. J Hematother 1996; 5: 179–84
   PubMedGoogle Scholar
• Dunbar C. E., Cottier-Fox M., O'Shaughnessy J. A., Doren S., Carter C., Berenson R., Brown S., Moen R. C., Greenblatt J., Stewart F. M., et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048–57
   PubMed Web of Science ®Google Scholar
• Kohn D. B., Weinberg K. I., Nolta J. A., Heiss L. N., Lenarsky C., Crooks G. M., Hanley M. E., Annett G., Brooks J. S., el-Khoureiy A., et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1995; 1: 1017–23
   PubMed Web of Science ®Google Scholar
• Kohn D. B., Bauer G., Rice C. R., Rothschild J. C., Carbonaro D. A., Valdez P., Hao Q., Zhou C., Banner I., Kearns K., Brody K., Fox S., Haden E., Wilson K., Salata C., Dolan C., Wetter C., Aguilar-Cordova E., Church J. A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood 1999; 94: 368–71
   PubMed Web of Science ®Google Scholar
• Moscow J. A., Huang H., Carter C., Hines K., Zujewski J., Cusack G., Chow C., Venzon D., Sorrentino B., Chiang Y., Goldspiel B., Leitman S., Read E. J., Abati A., Gottesman M. M., Pastan I., Sellers S., Dunbar C., Cowan K. H. Engraftment of MDRI and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy. Blood 1999; 94: 52–61
   PubMed Web of Science ®Google Scholar
• Aversa F., Tabilio A., Velardi A., Cunningham I., Terenzi A., Falzetti F., Ruggeri L., Barbabietola G., Aristei C., Lantini P., Reisner Y., Martelli M. F. Treatment of high-risk leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. New Eng. J. Med 1998; 339: 1186–1193
   PubMed Web of Science ®Google Scholar
• Kawano Y., Takaue Y., Watanabe A., Takeda O., Arai K., Itoh E., Ohno Y., Teshima T., Harada M., Watanabe T., Okamoto Y., Abe T., Kajiume T., Matsushita T., Ikeda K., Endo M., Kuroda Y., Asano S., Tanosaki R., Yamaguchi K., Law P., McMannis J. D. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor. Blood 1998; 92: 3123–30
   PubMed Web of Science ®Google Scholar
• Bruno B., Nash R. A., Wallace P. M., Gass M. J., Thompson J., Storb R., McSweeney P. A. CD34+ selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation. Transplantation 1999; 68: 338–44
   PubMed Web of Science ®Google Scholar
• Brown J., Greaves M. F., Molgaard H. V. The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int. Immunol 1991; 3: 175–84
   PubMed Web of Science ®Google Scholar
• Krause D. S., Ito T., Fackler M. J., Collector M. I., Sharkis S. J., May W. S. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 1994; 84: 691–701
   PubMed Web of Science ®Google Scholar
• Morel E., Szilvassy S., Travis M., Chen B., Galy A. Primitive hematopoietic cells in murine bone marrow express the CD34 antigen. Blood 1996; 88: 3774–3784
   PubMed Web of Science ®Google Scholar
• Kamel-Reid S., Dick J. E. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988; 242: 1706–9
   PubMed Web of Science ®Google Scholar
• McCune J. M., Namikawa R., Kaneshima H., Shultz L. D., Lieberman M., Weissman I. L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632–9
   PubMed Web of Science ®Google Scholar
• Uchida N., Aguila H. L., Fleming W. H., Jerabek L., Weissman I. L. Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1 lo Lin-Sca-1+ hematopoietic stem cells. Blood 1994; 83: 3758–79
   PubMed Web of Science ®Google Scholar
• Baum C. M., Weissman I. L., Tsukamoto A. S., Buckle A. M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A 1992; 89: 2804–8
   PubMed Web of Science ®Google Scholar
• DiGiusto D., Chen S., Combs J., Webb S., Namikawa R., Tsukamoto A., Chen B. P., Galy A. H. M. Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 1994; 84: 421–32
   PubMed Web of Science ®Google Scholar
• Chen B. P., Galy A., Kyoizumi S., Namikawa R., Scarborough J., Webb S., Ford B., Cen D. Z., Chen S. C. Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. Blood 1994; 84: 2497–505
   PubMed Web of Science ®Google Scholar
• Serreze D. V., Leiter E. H., Hanson M. S., Christianson S. W., Shultz L. D., Hesselton R. M., Greiner D. L. An improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells. Diabetes 1995; 44: 1392–98
   PubMed Web of Science ®Google Scholar
• Bhatia M., Wang J. C. Y., Kapp U., Bonnet D., Dick J. E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. USA 1997; 94: 5320–25
   PubMed Web of Science ®Google Scholar
• Bhatia R., McGlave P. B., Miller J. S., Wissink S., Lin W. N., Verfaillie C. M. A clinically suitable ex vivo expansion culture system for LTC-1C and CFC using stroma-conditioned medium. Experimental Hematology 1997; 25: 980–991
   PubMed Web of Science ®Google Scholar
• Cashman J., Bockhold K., Hogge D. A., Eaves A. C., Eaves C. J. Sustained proliferation, multi-lineage differentiation and maintenance of primitive human haemopoietic cells in NOD/SCID mice transplanted with human cord blood. Br. J. Haematol 1997; 97: 1026–36
   Web of Science ®Google Scholar
• Hogan C. J., Shpall E. J., McNulty O., McNiece I., Dick J. E., Shultz L. D., Keller G. Engraftment and development of human CD34+-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 1997; 90: 85–96
   PubMed Web of Science ®Google Scholar
• Flake A. W., Harrison M. R., Adzick N. S., Zanjani E. D. Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science 1986; 233: 776–8
   PubMed Web of Science ®Google Scholar
• Srour E., Zanjani E., Brandt J., Leemhuis T., Briddell R. A., Heerema N. A., Hoffman R. Sustained human hematopoiesis in sheep translated in utero during early gestation with fractionated adult human bone marrow cells. Blood 1992; 79: 1404
   PubMed Web of Science ®Google Scholar
• Srour E. E., Zanjani E. D., Cornetta K., Traycoff C. M., Flake A. W., Hedrick M., Brandt J. E., Leemhuis T., Hoffman R. Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. Blood 1993; 82: 3333–3342
   PubMed Web of Science ®Google Scholar
• Zanjani E. D., Almeida-Porada G., Livingston A. G., Porada C. D., Ogawa M. Engraftment and multilineage expression of human bone marrow CD34-cells in vivo. Ann N Y Acad Sci 1999; 872: 220–31, discussion 231–2
   PubMed Web of Science ®Google Scholar
• Civin C. I., Almeida-Porada G., Lee M. J., Olweus J., Terstappen L. W., Zanjani E. D. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood 1996; 88: 4102–9
   PubMed Web of Science ®Google Scholar
• Kawashima I., Zanjani E., Almaida-Porado G., Flake A., Zeng H., Ogawa M. CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood 1996; 87: 4136–42
   PubMedGoogle Scholar
• Ziegler B. L., Valtieri M., Porada G. A., De Maria R., Muller R., Masella B., Gabbianelli M., Casella I., Pelosi E., Bock T., Zanjani E. D., Peschle C. KDR receptor: a key marker defining hematopoietic stem cells. Science 1999; 285: 1553–8
   PubMed Web of Science ®Google Scholar
• Bock T. A., Ziegler B. L., Buhring H. J., Scheding S., Brugger W., Kanz L. Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipients. Ann N Y Acad Sci 1999; 872: 200–7, discussion 207–10
   PubMed Web of Science ®Google Scholar
• Conneally E., Cashman J., Petzer A., Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc. Natl. Acad. Sci. USA 1997; 94: 9836–41
   PubMed Web of Science ®Google Scholar
• Piacibello W., Sanavio E., Severino A., Dane A., Gammaitoni L., Fagioli E., Perissinotto E., Cavalloni G., Kollet O., Lapidot T., Aglietta M. Engraftment in non-obese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999; 93: 3736–49
   PubMed Web of Science ®Google Scholar
• Glimm H., Eaves C. J. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood 1999; 94: 2161–8
   PubMed Web of Science ®Google Scholar
• Young J. C., Lin K., Hansteen G., Travis M., Murray L. J., Jaing L., Scollay R., Hill B. L. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo. Exp Hematol 1999; 27: 994–1003
   PubMed Web of Science ®Google Scholar
• Brandt J. E., Bartholomew A. M., Fortman J. D., Nelson M. C., Bruno E., Chen L. M., Turian J. V., Davis T. A., Chute J. P., Hoffman R. Ex vivo expansion of autologous bone marrow CD34(+) cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons. Blood 1999; 94: 106–13
   PubMed Web of Science ®Google Scholar
• Spangrude G. J., Heimfeld S., Weissman I. L. Purification and characterization of mouse hematopoietic stem cells. Science 1988; 241: 58–62
   PubMed Web of Science ®Google Scholar
• Li C. L., Johnson G. R. Long-term hemopoietic repopulation by Thy-llo, Lin-, Ly6A/E+ cells. Exp Hematol 1992; 20: 1309–15
   PubMed Web of Science ®Google Scholar
• Uchida N., Weissman I. Searching for hematopoietic stem cells: evidence that Thy-l.llo Lin-Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-l.l bone marrow. J Exp Med 1992; 175: 175–84
   PubMed Web of Science ®Google Scholar
• Spangrude G. J., Brooks D. M. Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly-6A/E by bone marrow cells. Blood 1993; 82: 3327–32
   PubMed Web of Science ®Google Scholar
• Okada S., Nakauchi H., Nagayoshi K., Nishikawa S., Nishikawa S. -I., Miura Y., Suda T. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 1991; 78: 1706–12
   PubMedGoogle Scholar
• Okada S., Nakauchi H., Nagayoshi K., Nishikawa S. -L., Miura Y., Suda T. In vivo and in vivo stem cell function of c-kit-and Sea-1-positive murine hematopoietic cells. Blood 1992; 80: 3044–3050
   PubMed Web of Science ®Google Scholar
• Osawa M., Hanada K., Hamada H., Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996; 273: 242–245
   PubMed Web of Science ®Google Scholar
• Osawa M., Nakamura K., Nishi N., Takahashi N., Tokuomoto Y., Inoue H., Nakauchi H. In vivo self-renewal of c-Kit+ Sca-1+ Linlow/- hemopoietic stem cells. Journal of Immunology 1996; 156: 3207–3214
   PubMed Web of Science ®Google Scholar
• Katayama N., Shin J. P., Nishikawa S., Kina T., Clark S. C., Ogawa M. Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 1993; 82: 2353–60
   PubMed Web of Science ®Google Scholar
• Ogawa M., Shih J. P., Katayama N. Enrichment for primitive hemopoietic progenitors of marrow cells from 5-fluorouracil-treated mice and normal mice. Blood Cells 1994; 20: 7–11
   PubMedGoogle Scholar
• Doi H., Inaba M., Yamamoto Y., Taketani S., Mori S. I., Sugihara A., Ogata H., Toki J., Hisha H., Inaba K., Sogo S., Adachi M., Matsuda T., Good R. A., Ikehara S. Pluripotent hemopoietic stem cells are c-kitlow. Proc Natl Acad Sci U S A 1997; 94: 2513–7
   PubMed Web of Science ®Google Scholar
• Ortiz M., Wine J. W., Lohrey N., Ruscetti F. W., Spence S. E., Keller J. R. Functional characterization of a novel hematopoietic stem cell and its place in the c-Kit maturation pathway in bone marrow cell development. Immunity 1999; 10: 173–82
   PubMed Web of Science ®Google Scholar
• Gunji Y., Nakamura M., Osawa H., Nagayoshi K., Nakauchi H., Miura Y., Yanagisawa M., Suda T. Human primitive hematopoietic progenitor cells are more enriched in KITlow cells that in KIThigh cells. Blood 1993; 82: 3283–89
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y., Gunji Y., Nakamura M., Hayakawa K., Maeda M., Osawa H., Nagayoshi K., Kasahara T., Suda T. Expression of c-kit mRNA and protein during the differentiation of human hematopoietic progenitor cells. Exp Hematol 1993; 21: 1233–8
   PubMed Web of Science ®Google Scholar
• Nakauchi H., Takano H., Ema H., Osawa M. Further characterization of CD34- low/negative mouse hematopoietic stem cells. Ann N Y Acad Sci 1999; 872: 57–66, discussion 66–70
   PubMed Web of Science ®Google Scholar
• Jones R. J., Collector M. I., Barber J. P., Vala M. S., Fack-ler M. J., May W. S., Griffin C. A., Hawkins A. L., Zehnbauer B. A., Hilton J., Colvin O. M., Sharkis S. J. Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood 1996; 88: 487–91
   PubMed Web of Science ®Google Scholar
• Goodell M. A., Brose K., Paradis G., Conner A. S., Mulligan R. C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med 1996; 183: 1797–1806
   PubMed Web of Science ®Google Scholar
• Goodell M. A., Rosenzweig M., Kim H., Marks D. F., DeMaria M., Paradis G., Grupp S. A., Sieff C. A., Mulligan R. C., Johnson R. P. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med 1997; 3: 1337–45
   PubMed Web of Science ®Google Scholar
• Johnson B. D., Hanke C. A., Truitt R. L. The graft-versus-leukemia effect of post-transplant donor leukocyte infusion. Leuk Lymphoma 1996; 23: 1–9
   PubMed Web of Science ®Google Scholar
• Hansteen G., Reitsma M., Travis M., Hill B. CD34+, but not CD34-cells with the human hoescht 33342 “side population” possess primitive pluropotent progenitor activity. Blood 1997; 90: 160a
   Google Scholar
• Bhatia M., Bonnet D., Burdoch B., Gan O. I., Dick J. E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nature Med 1998; 4: 1038–45
   PubMed Web of Science ®Google Scholar
• Dick J. E. Absence of CD34 on some human SCID-repopulating cells. Ann N Y Acad Sci 1999; 872: 211–7, discussion 217–9
   PubMed Web of Science ®Google Scholar
• Wang J. C., Doedens M., Dick J. E. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997; 89: 3919–24
   PubMed Web of Science ®Google Scholar
• Zanjani E. D., Almeida-Porada G., Livingston A. G., Flake A. W., Ogawa M. Human bone marrow CD34” cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp. Hematol 1998; 26: 353–60
   PubMed Web of Science ®Google Scholar
• Fujisaki T., Berger M. G., Rose-John S., Eaves C. J. Rapid differentiation of a rare subset of adult human lin(-)CD34(-)CD38(-) cells stimulated by multiple growth factors in vitro. Blood 1999; 94: 1926–32
   PubMed Web of Science ®Google Scholar
• Nakamura Y., Ando K., Chargui J., Kawada H., Sato T., Tsuji T., Hotta T., Kato S. Ex Vivo Generation of CD34(+) Cells From CD34(-) Hematopoietic Cells. Blood 1999; 94: 4053–4059
   PubMed Web of Science ®Google Scholar
• Morel F., Galy A., Chen B., Szilvassy S. Characterization of CD34 negative hematopoietic stem cells in murine bone marrow. Blood 1996; 88: 629a, abstract
   Google Scholar
• Morel F., Galy A., Chen B., Szilvassy S. Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34-fractions of Thy-llow-Lin-/lowSca-l+ bone marrow cells. Exp Hematol 1998; 26: 440–8
   PubMed Web of Science ®Google Scholar
• Donnelly D. S., Zelterman D., Sharkis S., Krause D. S. Functional activity of murine CD34+ and CD34-hematopoietic stem cell populations. Exp Hematol 1999; 27: 788–96
   PubMed Web of Science ®Google Scholar
• Kim D., Fujika Y., Fukushima T., Etna H., Shibuya A., Nakauchi H. Comparison of hematopoietic activities of human bone marrow and umbilical cord blood CD34 positive and negative cells. Stem cells 1999; 17: 286–84
   PubMed Web of Science ®Google Scholar
• Sato T., Laver J. H., Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells [see comments]. Blood 1999; 94: 2548–54
   PubMed Web of Science ®Google Scholar
• Huss R., Hong D. S., McSweeney P. A., Hoy C. A., Deeg H. J. Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursor. Proc Natl Acad Sci U S A 1995; 92: 748–52
   PubMed Web of Science ®Google Scholar
• Lange C., Kaltz C., Thalmeier K., Kolb H. J., Huss R. Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34-, Sca-1+, Thy-1 (low), c-kit+ stem cell line [In Process Citation]. J Hematother Stem Cell Res 1999; 8: 335–42
   PubMedGoogle Scholar
• Metcalf D. Stem cells, pre-progenitor cells and lineage-committed cells: are our dogmas correct?. Ann N Y Acad Sci 1999; 872: 289–303, discussion 303–4
   PubMed Web of Science ®Google Scholar
• Cooper D. D., Spangrude G. J. (R)evolutionary considerations in hematopoietic development. Ann N Y Acad Sci 1999; 872: 83–93
   PubMed Web of Science ®Google Scholar
• Bradford G. B., Williams B., Rossi R., Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp. Hematol 1997; 25: 445–53
   PubMed Web of Science ®Google Scholar
• Cheshier S. H., Morrison S. J., Liao X., Weissman I. L. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A 1999; 96: 3120–5
   PubMed Web of Science ®Google Scholar